Safety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy Adults | MicrobiomeTrials← Back to trialsNCT05891236
Safety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy Adults
CompletedPHASE1INTERVENTIONAL
Trial Details
Start: 2023-08-14Est. Completion: 2024-12-13
Enrollment target: 63 participants Locations- Center for Vaccine Development and Global Health, 685 W. Baltimore Street, Baltimore, Maryland, United States
Other microbiome trials you might be interested in
Malaria, Falciparum
This is a single-centre, participant- and investigator-blind, randomised, placebo controlled, single ascending dose stud…
Nottingham, United KingdomEst. completion Dec 2, 2027
Malaria
Background:
Malaria is a disease that affects many people in Africa. It is caused by germs carried by some mosquitoes. …
Ou(SqrRoot)(Copyright)less(SqrRoot)(Copyright)bougou, MaliCompleted Nov 30, 2026
Completed
Red Blood CellsSchistocytesArtificial Intelligence
Erythrocyte morphology analysis is a key step in the diagnosis flowchart of anemia. It is performed on a peripheral bloo…
Amiens, FranceCompleted Feb 28, 2022